市场调查报告书
商品编码
1451705
2024-2032 年按类型(抗生素、激素、人工泪液等)、应用(眼部疾病、眼部护理)和地区分類的滴眼剂和润滑剂市场报告Eye Drops and Lubricants Market Report by Type (Antibiotics, Hormones, Artificial Tears, and Others), Application (Eye Diseases, Eye Care), and Region 2024-2032 |
2023年,全球眼药水和润滑剂市场规模达到210亿美元。展望未来, IMARC Group预计到2032年市场规模将达到314亿美元,2024-2032年复合年增长率(CAGR)为4.4%。眼部疾病病例的不断增加、製药行业研发活动的增加以及旨在最大程度地降低干眼症相关风险的荷尔蒙疗法的日益普及是推动市场发展的一些主要因素。
眼药水和润滑剂是用于维持和改善眼睛健康的重要产品。它们旨在缓解各种眼睛不适、润滑眼睛并促进整体眼睛健康。它们由人工泪液和血管收缩剂组成,透过收缩眼睛中的血管来帮助缓解发红。它们有多种配方可供选择,以解决特定的眼睛状况和症状。它们用于预防由干燥环境、长时间看萤幕、过敏或某些医疗状况等因素引起的干燥、发红、搔痒和刺激。
目前,对缓解症状和缓解眼睛不适的眼药和润滑剂的需求不断增长,推动了市场的成长。除此之外,人们对使用滴眼剂和润滑剂的有益方面以及采取适当眼睛护理的必要性的认识不断提高,也促进了市场的成长。此外,用于最大限度降低干眼症相关风险的荷尔蒙疗法的日益普及也带来了良好的市场前景。除此之外,透过零售药局提供的开角型青光眼治疗药物的数量不断增加正在支持市场的成长。此外,老年人口中各种与年龄相关的眼部疾病的发生率不断上升正在推动市场的成长。此外,越来越多地采用技术先进的方法来製造安全性和有效性提高的创新滴眼剂和润滑剂,这也促进了市场的成长。
眼部疾病病例不断增加
干眼症、结膜炎和青光眼等眼部疾病的盛行率不断上升,是眼药水和润滑剂市场的主要动力。除此之外,长时间使用数位设备、环境污染和生活方式的改变也导致这些疾病的发生率不断上升。此外,糖尿病、高血压和肥胖等与生活方式选择有关且在全球范围内呈上升趋势的疾病也会影响眼睛健康。例如,糖尿病视网膜病变是影响眼睛的糖尿病併发症。此外,快速的城市化和污染的加剧也导致了眼部疾病的增加。接触空气污染与干眼症和过敏性结膜炎等疾病有关。随着各种眼部疾病发生率的增加,世界各地对缓解与这些疾病相关的不适、搔痒、发红和干燥的滴眼剂和润滑剂的需求不断增加。
增加研究相关活动
目前,由于老化、生活方式的改变和环境因素引起的眼部疾病的盛行率不断增加,有效滴眼剂的开发不断增加。除此之外,随着技术的出现和随之而来的萤幕时间的增加,人们越来越容易受到眼睛疲劳和干燥的影响,从而推动了对创新解决方案的需求。此外,消费者不断变化的期望和需求促使研究人员寻找能够立即缓解眼睛不适并解决眼睛不适根本原因的新颖配方。传统的眼药水通常只能提供暂时的缓解作用,需要经常使用,并且不能充分解决干燥的根本原因或提供持久的滋润。因此,对能够提供持续润滑并有效恢復天然泪膜以促进眼睛舒适和健康的先进配方的需求不断增长,这鼓励研究人员开发高效的滴眼剂和润滑剂。
智慧型手机和平板电脑的使用不断增长
目前,智慧型手机、平板电脑、笔记型电脑等各种智慧型装置的使用日益增多,给使用者的眼睛带来了压力,导致干眼症的发病率上升。除此之外,智慧型手机配备了发射蓝光的高解析度萤幕,与光谱上的其他颜色相比,蓝光的波长更短,能量更高。过度接触蓝光会导致数位眼疲劳,也称为电脑视觉综合症。持续使用智慧型手机,通常伴随着长时间盯着萤幕,会加剧这些症状,导致眼疾患病率上升。此外,过度使用智慧型手机导致各种眼部併发症的发生以及各种眼药水和润滑剂的使用增加。
The global eye drops and lubricants market size reached US$ 21.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 31.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.4% during 2024-2032. The growing cases of eye disorders, rising research and development (R&D) activities in the pharmaceutical sector, and increasing popularity of hormone therapy to minimize the risks associated with dry eye syndrome are some of the major factors propelling the market.
Eye drops and lubricants are essential products used for maintaining and improving eye health. They are designed to provide relief from various eye discomforts, lubricate the eyes, and promote overall eye health. They consist of artificial tears and vasoconstrictors, which help to ease redness by constricting the blood vessels in the eyes. They are available in a variety of formulations to address specific eye conditions and symptoms. They are used to prevent dryness, redness, itchiness, and irritation caused by factors, such as dry environments, prolonged screen time, allergies, or certain medical conditions.
At present, the increasing demand for eye drops and lubricants to alleviate symptoms and provide relief from discomfort in the eyes is impelling the growth of the market. Besides this, the rising awareness about the beneficial aspects of using eye drops and lubricants and the necessity of taking proper eye care is contributing to the growth of the market. In addition, the growing popularity of hormone therapy to minimize the risks associated with dry eye syndrome is offering a favorable market outlook. Apart from this, the increasing number of open-angle glaucoma therapeutics provided via retail pharmacies is supporting the growth of the market. Additionally, the rising occurrence of various age-associated eye disorders in the geriatric population is propelling the growth of the market. Moreover, the increasing adoption of technologically advanced methods to manufacture innovative eye drops and lubricants with improved safety and efficacy is bolstering the growth of the market.
Rising cases of eye diseases
The rising prevalence of eye disorders, including dry eye syndrome, conjunctivitis, and glaucoma, is a key driver for the eye drops and lubricants market. Apart from this, prolonged digital device usage, environmental pollution, and changing lifestyles contribute to the growing incidence of these conditions. In addition, conditions like diabetes, hypertension, and obesity, which are linked to lifestyle choices and are on the rise globally, can affect eye health. For instance, diabetic retinopathy is a complication of diabetes that affects the eyes. Moreover, rapid urbanization and increased pollution are contributing to the increase in eye diseases. Exposure to air pollution is linked to conditions like dry eye syndrome and allergic conjunctivitis. As there is an increase in the occurrence of various eye disorders, the demand for eye drops and lubricants to provide relief from discomfort, itching, redness, and dryness associated with these disorders is rising around the world.
Increasing research-related activities
At present, there is an increase in the development of effective eye drops due to the growing prevalence of eye diseases caused by aging, lifestyle changes, and environmental factors. Besides this, with the advent of technology and the consequent increase in screen time, individuals are increasingly susceptible to eye strain and dryness, thereby driving the demand for innovative solutions. In addition, evolving expectations and demands of consumers are prompting researchers to seek novel formulations that provide instant relief and address the underlying causes of eye discomfort. Traditional eye drops often offer temporary relief, necessitating frequent application, and do not adequately address the root causes of dryness or provide long-lasting moisture. Consequently, the growing need for advanced formulations that can provide sustained lubrication and effectively restore the natural tear film to promote ocular comfort and health is encouraging researchers to develop efficient eye drops and lubricants.
Growing utilization of smartphones and tablets
At present, the increasing utilization of various smart devices, including smartphones, tablets, and laptops, is exerting stress on the eyes of users and raising the incidence of dry eye disease in individuals. Besides this, smartphones are equipped with high-resolution screens that emit blue light, which has a shorter wavelength and higher energy compared to other colors on the light spectrum. Excessive exposure to blue light leads to digital eye strain, also called computer vision syndrome. The constant use of smartphones, often accompanied by prolonged periods of staring at screens, exacerbates these symptoms, contributing to the rising prevalence of eye diseases. Furthermore, the excessive use of smartphones is leading to an increase in the occurrence of various eye complications and the use of various eye drops and lubricants.
IMARC Group provides an analysis of the key trends in each segment of the global eye drops and lubricants market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on the type and application.
Antibiotics
Hormones
Artificial Tears
Others
Artificial tears dominate the market
The report has provided a detailed breakup and analysis of the market based on the type. This includes antibiotics, hormones, artificial tears, and others. According to the report, artificial tears represented the largest segment.
Artificial tears are non-prescription, over-the-counter eye drops that are used to treat symptoms associated with dry eyes. They are designed to mimic the natural tears produced by our eyes and are a blend of water, salts, and polymers that enhance viscosity and lubrication. Artificial tears provide immediate symptoms associated with dry eye syndrome, such as burning, irritation, redness, and a sensation of having something in your eyes. Artificial tears also help maintain the health and integrity of the ocular surface. By providing a surrogate for the natural tear film, they ensure the eye remains well-hydrated and nourished, reducing the risk of damage to the cornea.
Eye Diseases
Dry Eye
Glaucoma
Conjunctivitis
Refractive Errors
Others
Eye Care
Eye diseases hold the largest share in the market
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes eye diseases (dry eye, glaucoma, conjunctivitis, refractive errors, and others) and eye care. According to the report, eye diseases (dry eye, glaucoma, conjunctivitis, refractive errors, and others) accounted for the largest market share.
Eye drops and lubricants are significant tools in the management and treatment of a multitude of ocular conditions. The way they help cure eye diseases is multifaceted, depending on the active ingredient in the drops and the nature of the disease. They provide symptomatic relief by mimicking the natural tear film and lubricating the ocular surface. They are also used to treat bacterial infections, such as conjunctivitis (pink eye) or corneal ulcers. These medications contain substances that inhibit the growth of bacteria or kill them outright. They function by interfering with the replication of viruses while limiting the spread of infection and speed up the healing process.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest eye drops and lubricant market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the rising occurrence of dry eye syndrome, glaucoma, age-related macular degeneration, and cataracts among the aging population. Besides this, the prolonged screen time causing digital eye strain and dry eyes among the masses is propelling the growth of the market.
Another contributing aspect is the rising occurrence of eye allergies caused by climate change and rising levels of pollution. In addition, the increasing advancement in eye care treatments is supporting the growth of the market.
Asia Pacific is estimated to expand further in this domain due to the rising utilization of smartphones and laptops to access the internet. In addition, the growing construction of eye hospitals offering efficient eyecare services is positively influencing the market.
Key market players are investing in research operations to innovate and improve their eye drops and lubricants. They are also focusing on developing advanced formulations, ingredients, and delivery systems to enhance the effectiveness and comfort of their products. Top companies are striving to expand their product portfolios by introducing new eye drops and lubricants that cater to different consumer needs. They are also offering specialized products for dry eye relief, allergy relief, redness reduction, contact lens lubrication, and other specific eye care concerns. Leading companies are collaborating with healthcare professionals, including ophthalmologists and optometrists, to gain insights into patient needs and develop products tailored to those needs.
Akorn Operating Company LLC
Alcon
Allergan Plc (AbbVie Inc.)
Bausch & Lomb Incorporated
Bayer AG
Johnson & Johnson
Maya Biotech Private Limited
Prestige Consumer Healthcare Inc.
Rohto Pharmaceutical Co. Ltd.
Sager Pharma Kft
Similasan Corporation
In June 2019, Akorn Operating Company LLC announced the launch of its first-to-market generic of Loteprednol Etabonate Ophthalmic Suspension, 0.5%, which is used for treating post-operative inflammation following ocular surgery.
In November 2022, Alcon announced the acquisition of Aerie Pharmaceuticals Inc., which will help to bolster Alcon's presence in the ophthalmic pharmaceutical space with its growing portfolio of commercial items and development pipeline.
In October 2019, Allergan Plc (AbbVie Inc.) announced the launch of three novel over-the-counter REFRESH RELIEVA products comprising a new line of artificial tear formulations that are suitable for contact lens wearers.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.